0001209191-21-066102.txt : 20211122
0001209191-21-066102.hdr.sgml : 20211122
20211122163037
ACCESSION NUMBER: 0001209191-21-066102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211118
FILED AS OF DATE: 20211122
DATE AS OF CHANGE: 20211122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YEAMAN KEVIN J
CENTRAL INDEX KEY: 0001200469
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 211432922
MAIL ADDRESS:
STREET 1: C/O DOLBY LABORATORIES, INC.
STREET 2: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0927
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-18
0
0001308547
Dolby Laboratories, Inc.
DLB
0001200469
YEAMAN KEVIN J
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
1
1
0
0
President and CEO
Class A Common Stock
2021-11-18
4
M
0
29457
42.98
A
62352
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Class A Common Stock
2021-11-18
4
S
0
4017
87.7074
D
58335
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Class A Common Stock
2021-11-18
4
S
0
5672
88.8223
D
52663
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Class A Common Stock
2021-11-18
4
S
0
6283
89.788
D
46380
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Class A Common Stock
2021-11-18
4
S
0
13485
90.8093
D
32985
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Class A Common Stock
106414
D
Employee Stock Option (right to buy)
42.98
2021-11-18
4
M
0
29457
0.00
D
2024-12-15
Class A Common Stock
29457
247414
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
The shares were sold in multiple transactions at prices ranging from $87.24 to $88.22, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $88.34 to $89.15 inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $89.37 to $90.34, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $90.46 to $91.18, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Shares held following the reported transactions include 106,414 restricted stock units, which are subject to forfeiture until they vest.
This option was granted for a total of 291,598 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.
**All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.**
/s/ Daniel Rodriguez, Attorney-in-Fact for Kevin Yeaman
2021-11-18